Format

Send to

Choose Destination
Minerva Ginecol. 2018 Aug;70(4):402-407. doi: 10.23736/S0026-4784.18.04232-6. Epub 2018 Apr 11.

Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.

Author information

1
Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium - marie-madeleine.dolmans@uclouvain.be.
2
Department of Gynecology, Cliniques Universitaires Saint-Luc, Brussels, Belgium - marie-madeleine.dolmans@uclouvain.be.
3
Catholic University of Louvain, Brussels, Belgium.
4
Société de Recherche pour l'Infertilité (SRI), Brussels, Belgium.

Abstract

Oocyte vitrification and ovarian tissue cryopreservation are two common fertility preservation options. Oocyte vitrification provides the highest yield for women with benign diseases or those seeking fertility preservation for age-related fertility decline. This technique is also indicated for cancer women if cancer treatment can be postponed. Ovarian tissue cryopreservation has some specific indications. There is indeed no other alternative for fertility preservation in prepubertal girls, and in cancer women in whom cancer treatment cannot be postponed. This review focuses on the indications for fertility preservation from malignant diseases to benign conditions to age-related fertility decline.

PMID:
29644332
DOI:
10.23736/S0026-4784.18.04232-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Minerva Medica
Loading ...
Support Center